Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and proteinase K-resistant PrP(Sc) levels in peripheral tissue from a murine transgenic model of TSE disease
- PMID: 23487470
- PMCID: PMC3648199
- DOI: 10.1128/JVI.03469-12
Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and proteinase K-resistant PrP(Sc) levels in peripheral tissue from a murine transgenic model of TSE disease
Abstract
Most current diagnostic tests for transmissible spongiform encephalopathies (TSE) rely on the presence of proteinase K (PK)-resistant PrP(Sc) (PrP-res) in postmortem tissues as an indication of TSE disease. However, a number of studies have highlighted a discrepancy between TSE infectivity and PrP-res levels in both natural and experimental cases of TSE disease. Previously, we have shown high TSE infectivity levels in the brain tissue of mice that have a clinical TSE disease with associated vacuolar pathology but little or no detectable PrP-res. Here, the levels of TSE infectivity and PrP-res within a peripheral tissue of this mouse model were investigated. Biochemical analysis showed that low levels of PrP-res were present in the spleen tissue in comparison to the levels observed in the spleen of mice infected with ME7 or 79A. However, upon subpassage of brain and spleen tissue from clinically ill mice with little or no PrP-res detectable, similar short incubation periods to disease were observed, indicating that infectivity levels were similarly high in both tissues. Thus, the discrepancy between PrP-res and TSE infectivity was also present in the peripheral tissues of this disease model. This result indicates that peripheral tissues can contain higher levels of infectivity given the correct combination of host species, PrP genotype, and TSE agent. Therefore, the assumption that the levels of peripheral infectivity are lower than those in the central nervous system is not always correct, and this could have implications for current food safety regulations.
Figures
References
-
- Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136–144 - PubMed
-
- Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, Fournier JG, Hauw JJ, Rossier J, Dormont D. 1997. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402–405 - PubMed
-
- Race R, Meade-White K, Raines A, Raymond GJ, Caughey B, Chesebro B. 2002. Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J. Infect. Dis. 186(Suppl 2):S166–S170 - PubMed
-
- Andréoletti O, Berthon P, Marc D, Sarradin P, Grosclaude J, van Keulen L, Schelcher F, Elsen JM, Lantier F. 2000. Early accumulation of PrP(Sc) in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J. Gen. Virol. 81:3115–3126 - PubMed
-
- Mohri S, Farquhar CF, Somerville RA, Jeffrey M, Foster J, Hope J. 1992. Immunodetection of a disease specific PrP fraction in scrapie-affected sheep and BSE-affected cattle. Vet. Rec. 131:537–539 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- BBS/E/D/20251967/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BB/D526429/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BBS/E/D/05241340/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BB/J004332/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BBS/E/D/20251968/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
